Japanese companies consider participation in Silk Road Economic Belt
Saakashvili says state corporations under Yatsenuyk government have cost Ukraine $4.5 bln
Poroshenko says ceasefire observed in Donbas for 6 days
NATO aircraft far more active than Russian planes — Russia’s permanent mission to NATO
Putin: Early to speak of Russia’s readiness for military participation in fight against IS
Some 80 agreements totalling 1,3 trillion roubles signed at EEF - Vice Premier TrutnevEconomy September 05, 7:36
Putin’s speech at EEF 2015 shows Russia determined to develop Far East - Wang YangEconomy September 05, 3:18
Moscow celebrating its 868th anniversaryNon-political September 05, 1:56
DPR parliament sends its speaker to resignation, Pushilin appointed acting speakerWorld September 05, 0:28
Saakashvili says state corporations under Yatsenuyk government have cost Ukraine $4.5 blnWorld September 05, 0:03
Transaero airline says no restrictions on reservations for its flightsEconomy September 05, 0:00
Tajik defence ministry refutes media allegations about death of 25 servicemenWorld September 04, 23:19
Sweden’s actions in respect of Russian diplomatic assets unlawful — Foreign MinistryRussia September 04, 21:44
Poroshenko signs law on first elections in unified territorial communities on October 25World September 04, 21:32
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.